PERSONAL PRIVACY AND THE PUBLIC INTERESTBRECKENRIDGE A. C.HUMANITAS. 1975, Vol 11, Num 1, pp 75-83Article

ORAL ANTICOAGULANT DRUGS. PHARMACOKINETIC ASPECTS.BRECKENRIDGE A.1978; SEMINARS HEMATOL.; U.S.A.; DA. 1978; VOL. 15; NO 1; PP. 19-26; BIBL. 1 P. 1/2Article

POSSIBLE HAZARDS OF SEX HORMONE REPLACEMENT THERAPYBRECKENRIDGE A.1979; ADVERSE DRUG REACT. BULL.; GBR; DA. 1979; NO 76; 4 P.; BIBL. 15 REF.Serial Issue

ORAL ANTICOAGULANTS-THE TOTEM AND THE TABOO = ANTICOAGULANTS ORAUX: LE TOTEM ET LE TABOUBRECKENRIDGE A.1976; BRIT. MED. J.; G.B.; DA. 1976; NO 6007; PP. 419-423; BIBL. 60 REF.Article

ANTIPYRINE HALF-LIFE AND DRUG ELIMINATIONBRECKENRIDGE A.1980; CLIN. PHARMACOKINET; NLD; DA. 1980; VOL. 5; NO 3; PP. 201-203; BIBL. 2 P.Article

Clinical pharmacology and therapeuticsBRECKENRIDGE, A.BMJ. British medical journal (International ed.). 1995, Vol 310, Num 6976, pp 377-380, issn 0959-8146Article

A clinical pharmacologist's view of drug toxicityBRECKENRIDGE, A.British journal of clinical pharmacology. 1996, Vol 42, Num 1, pp 53-58, issn 0306-5251Article

Science, medicine and clinical pharmacology : the Lilly Lecture 1994BRECKENRIDGE, A.British journal of clinical pharmacology. 1995, Vol 40, Num 1, pp 1-9, issn 0306-5251Article

Clinical pharmacology in the United Kingdom : a view for the 1990sBRECKENRIDGE, A.British journal of clinical pharmacology. 1991, Vol 31, Num 3, pp 249-250, issn 0306-5251, 2 p.Article

Risks and benefits of prophylactic antimalarial drugsBRECKENRIDGE, A.British medical journal (1857). 1989, Vol 6707, Num 299, pp 1057-1058, issn 0007-1447, 2 p.Article

PLASMA UREA IN HYPERTENSIVE PATIENTS.BULPITT CJ; BRECKENRIDGE A.1976; BRIT. HEART J.; G.B.; DA. 1976; VOL. 38; NO 7; PP. 689-694; BIBL. 13 REF.Article

Clinical pharmacology in the 1990s : a personal perspectiveBRECKENRIDGE, A.The Clinical investigator. 1993, Vol 71, Num 6, pp 478-479, issn 0941-0198Article

INTERACTIONS OF BENZODIAZEPINES WITH WARFARINORME M; BRECKENRIDGE A; BROOKS RV et al.1972; BRIT. MED. J.; G.B.; DA. 1972; VOL. 3; NO 5827; PP. 611-614; BIBL. 11REF.Serial Issue

WARFARIN AND DISTALGESIC INTERACTIONORME M; BRECKENRIDGE A; COOK P et al.1976; BRIT. MED. J.; G.B.; DA. 1976; VOL. 6003; PP. 200; BIBL. 5 REF.Article

SHOULD EVERY SURVIVOR OF A HEART ATTACK BE GIVEN A BETA-BLOCKER. I: EVIDENCE FROM CLINICAL TRIALS. II: EVIDENCE FROM A CLINICAL PHARMACOLOGICAL STANDPOINT. III: SOME CONCLUSIONSHAMPTON JR; BRECKENRIDGE A; ROSE G et al.1982; BR. MED. J.; ISSN 0007-1447; GBR; DA. 1982; VOL. 285; NO 6334; PP. 33-40; BIBL. 34 REF.Article

INCREASED GLUCURONIDATION OF BILIRUBIN IN MAN AND RAT BY ADMINISTRATION OF ANTIPYRINE (PHENAZONE) = AUGMENTATION DE LA GLUCURONIDATION DE LA BILIRUBINE CHEZ L'HOMME ET LE RAT PAR L'ADMINISTRATION D'ANTIPYRINE (PHENAZONE)ORME M L'E; DAVIES L; BRECKENRIDGE A et al.1974; CLIN. SCI. MOLEC. MED.; G.B.; DA. 1974; VOL. 46; NO 4; PP. 511-518; BIBL. 1P.Article

SIMULTANEOUS ONSET OF MALIGNANT HYPERTENSION IN IDENTICAL TWINS = APPARITION SIMULTANEE D'UNE HYPERTENTION MALIGNE CHEZ DES JUMEAUX IDENTIQUESLEWIS PJ; ARCHER DFJ; BRECKENRIDGE A et al.1973; BRIT. HEART J.; G.B.; DA. 1973; VOL. 35; NO 3; PP. 347-348; BIBL. 4 REF.Serial Issue

AN INDOCHINESE REFUGEE PSYCHIATRIC CLINIC: CULTURALLY ACCEPTED TREATMENT APPROACHESKINZIE JD; KIET ANH TRAN; BRECKENRIDGE A et al.1980; AM. J. PSYCHIATRY; ISSN 0002-953X; USA; DA. 1980; VOL. 137; NO 11; PP. 1429-1432; BIBL. 13 REF.Article

CHANGES IN PLASMA GAMMA -GLUTAMYL TRANSPEPTIDASE ACTIVITY ASSOCIATED WITH ALTERATIONS IN DRUG METABOLISM IN MAN = MODIFICATIONS DE L'ACTIVITE PLASMATIQUE DE LA GAMMA -GLUTAMYL TRANSPEPTIDASE ASSOCIEES A DES ALTERATIONS DU METABOLISME DES MEDICAMENTS CHEZ L'HOMMEWHITFIELD JB; MOSS DW; NEALE G et al.1973; BRIT. MED. J.; G.B.; DA. 1973; NO 5849; PP. 316-318; BIBL. 11REF.Serial Issue

IMMEDIATE DECREASE BY HYDROCORTISONE OF THE PLASMA HALF-LIFE OF ANTIPYRINE = REDUCTION IMMEDIATE PAR L'HYDROCORTISONE DE LA DEMI-VIE PLASMATIQUE DE L'ANTIPYRINEBRECKENRIDGE A; BURKE CW; DAVIES DS et al.1973; BRIT. J. PHARMACOL.; G.B.; DA. 1973; VOL. 47; NO 2; PP. 434-436; BIBL. 7 REF.Article

Pharmacoeconomics Comes of Age?WALLEY, T; BRECKENRIDGE, A.Clinical pharmacology and therapeutics. 2008, Vol 84, Num 2, pp 279-280, issn 0009-9236, 2 p.Article

Clinical pharmacokinetics of anthelmintic drugsEDWARDS, G; BRECKENRIDGE, A. M.Clinical pharmacokinetics. 1988, Vol 15, Num 2, pp 67-93, issn 0312-5963Article

Xamoterol, A β₁-adrenoceptor partial agonist: a new approach to heart failure, Interlaken, 1988BARNETT, D. B; BRECKENRIDGE, A.British journal of clinical pharmacology. 1989, Vol 28, issn 0306-5251, 91 p., suppl. 1Conference Proceedings

ACCENTUATION OF ETHANOL-INDUCED FATTY LIVER BY PHENOBARBITONE.MARSH AR; FRASER HS; BRECKENRIDGE A et al.1977; CLIN. SCI. MOLEC. MED.; G.B.; DA. 1977; VOL. 52; NO 2; PP. 219-222; BIBL. 23 REF.Article

I. Clinical pharmacology and therapeutics in undergraduate medical education in the UK : current statusWALLEY, T; BLIGH, J; ORME, M et al.British journal of clinical pharmacology. 1994, Vol 37, Num 2, pp 129-135, issn 0306-5251Article